Logo image of QURE

UNIQURE NV (QURE) Stock Analyst Ratings

NASDAQ:QURE - Nasdaq - NL0010696654 - Common Stock - Currency: USD

12.84  -0.12 (-0.93%)

After market: 12.85 +0.01 (+0.08%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to QURE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 36.91. This target is 187.43% above the current price.
QURE was analyzed by 19 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about QURE.
In the previous month the buy percentage consensus was at a similar level.
QURE was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
QURE Historical Analyst RatingsQURE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 12.8420.2032.6436.9173.50 - 57.32% 154.21% 187.43% 472.43%
QURE Current Analyst RatingQURE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-27 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-21 RBC Capital Reiterate Outperform -> Outperform
2024-12-19 Mizuho Maintains Neutral -> Neutral
2024-12-16 Stifel Maintains Buy -> Buy
2024-12-12 Goldman Sachs Maintains Neutral -> Neutral
2024-12-11 Leerink Partners Maintains Outperform -> Outperform
2024-12-11 Guggenheim Reiterate Buy -> Buy
2024-12-11 RBC Capital Maintains Outperform -> Outperform
2024-12-10 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-12-10 Raymond James Upgrade Outperform -> Strong Buy
2024-12-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-06 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-11-06 RBC Capital Maintains Outperform -> Outperform
2024-11-06 Goldman Sachs Maintains Neutral -> Neutral
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Outperform
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-02 Goldman Sachs Maintains Neutral -> Neutral
2024-07-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-08 Mizuho Maintains Neutral -> Neutral
2024-05-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-04 Mizuho Maintains Neutral -> Neutral
2024-03-01 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-29 Goldman Sachs Downgrade Buy -> Neutral
2024-01-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-01-16 RBC Capital Reiterate Outperform -> Outperform
2023-12-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-12-19 Mizuho Downgrade Buy -> Neutral